Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

AARTI DRUGS LTD. - 524348 - Board Meeting Intimation for Buyback Of The Fully Paid-Up Equity Shares Of The Company

 AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/03/2021 ,inter alia, to consider and approve In compliance with Regulation 29 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, it is hereby informed that meeting of Board of Directors of the Company is scheduled to be held on Friday, March 19, 2021, to consider inter alia, proposal of buyback of the fully paid-up equity shares of the Company including matters related/incidental thereto.
16-03-2021
Bigul

Aarti Drugs Ltd - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates
14-03-2021
Bigul

Aarti Drugs Soars Nearly 4% On Getting Nod Under Pharma Incentives Scheme

 Aarti Drugs: The government recently launched a Production-Linked Incentive Scheme to promote domestic manufacturing by incentivising pharma manufacturers to set up greenfield projects in India
08-03-2021
Bigul

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates.
06-03-2021
Bigul

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Please find attached the press release on the approval of PLI application by Aarti Speciality Chemicals Limited, a Wholly-owned Subsidiary of Aarti Drugs Limited.
06-03-2021
Bigul

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below.
04-03-2021
Bigul

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be meeting Investors/Analysts (Participants) as per the details below.
02-03-2021
Bigul

AARTI DRUGS LTD. - 524348 - Closure Of Subsidiary Company

 Pursuant to the Regulation 30 of the Listing Regulations, we wish to inform you that Pinnacle Life Science LLC, a Wholly Owned Subsidiary ("subsidiary") of the Company, incorporated at "International Free Zone Authority" (IFZA), Fujairah, UAE, has been closed / wound-up.
19-02-2021
Bigul

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates
19-02-2021
Bigul

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Analyst Meet
19-02-2021
Next Page
Close

Let's Open Free Demat Account